The DREAM Study: A Multidimensional Sleep Health Intervention for Improving Cardiometabolic Health
Addressing Sleep Duration, Regularity, and Efficiency: A Multidimensional Sleep Health Intervention for Improving Cardiometabolic Health (The DREAM Study)
2 other identifiers
interventional
200
1 country
1
Brief Summary
The purpose of this randomized clinical trial is to evaluate the impact of a multidimensional sleep health promotion intervention on blood pressure, glycemic control indicators, anthropometric markers of adiposity, and lifestyle factors in adults. Participants will be randomized into an intervention or a control group. The control arm will receive standard Life's Essential 8 cardiovascular health educational materials. The intervention arm will additionally receive a multi-component intervention aimed at improving sleep health based on evidence-based sleep hygiene education and established behavior change techniques that include personalized sleep health feedback, goal setting and establishing a sleep health plan, coaching, self-monitoring, and addressing light and noise in the sleep environment. Mixed methods will be used to understand implementation determinants, processes, and outcomes, ensuring the successful completion and future expansion of this intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2024
CompletedFirst Posted
Study publicly available on registry
February 29, 2024
CompletedStudy Start
First participant enrolled
March 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
ExpectedNovember 25, 2025
November 1, 2025
2.1 years
February 13, 2024
November 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in office systolic blood pressure
The change office systolic blood pressure (mmHg) from baseline to follow-up at 8 weeks will be calculated and compared across randomization arms.
Baseline, 8 weeks
Secondary Outcomes (13)
Change in office systolic blood pressure (sustained effect at 24 weeks)
Baseline, 24 weeks
Change in office diastolic blood pressure
Baseline, 8 weeks, and 24 weeks
Change in out-of-office blood pressure
Baseline, 8 weeks, and 24 weeks
Change in fasting glucose
Baseline, 8 weeks, and 24 weeks
Change in body weight
Baseline, 8 weeks, and 24 weeks
- +8 more secondary outcomes
Study Arms (2)
Multidimensional Sleep Health Promotion Intervention
EXPERIMENTALParticipants randomized to the intervention arm will receive: 1. A multi-component multidimensional sleep health promotion intervention that includes report back of sleep health profiles, S.M.A.R.T. goal setting, sleep health coaching, establishment of fixed sleep schedule, virtual sleep hygiene education, self-monitoring, personalized feedback and supportive accountability, and addressing light and noise in the sleep environment. 2. Cardiovascular health education materials based on the American Heart Association's Life's Essential 8 framework.
Standard of care
NO INTERVENTIONParticipants randomized to the control arm will receive standard American Heart Association Life's Essential 8 cardiovascular health education materials, providing guidance on healthy sleep duration only.
Interventions
Multi-component multidimensional sleep health promotion intervention that includes goal setting, action planning, sleep health coaching and sleep hygiene education, a fixed sleep schedule, self-monitoring, personalized feedback and supportive accountability, and addressing light and noise in the sleep environment.
Eligibility Criteria
You may qualify if:
- Adults aged 30-65 years
- English or Spanish speaking
- Systolic blood pressure greater than or equal to 120 mmHg
- Sub-optimal sleep health
- No history of overt cardiovascular disease
- No history of cancer
You may not qualify if:
- Optimal sleep health
- History of cardiovascular disease or cancer
- Non-English or non-Spanish speaking
- Not cognitively able to complete study requirements
- Severe psychiatric disorders
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia University Irving Medical Center, Mailman School of Public Health
New York, New York, 10032, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Nour Makarem, PhD
Columbia University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Epidemiology
Study Record Dates
First Submitted
February 13, 2024
First Posted
February 29, 2024
Study Start
March 12, 2024
Primary Completion
March 31, 2026
Study Completion (Estimated)
March 31, 2027
Last Updated
November 25, 2025
Record last verified: 2025-11